Overview

Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery

Status:
Completed
Trial end date:
2018-08-22
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and efficacy of FS VH S/D 500 s-apr for use as an adjunct to sutured dural repair in cranial surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Baxter Healthcare Corporation
Treatments:
Fibrin Tissue Adhesive